Zeo ScientifiX, Inc. 8-K

What Happened
Zeo ScientifiX, Inc. (ZEOX) filed a Form 8-K on July 21, 2026 (Item 8.01) announcing efforts to strengthen its role in South Florida’s healthcare innovation ecosystem through regenerative biologic research and development, physician education, and scientific collaboration. The company highlighted operations at Nova Southeastern University’s Center for Collaborative Research in Davie, Florida. A press release describing these initiatives is included as Exhibit 99.1 to the filing.

Key Details

• Form 8-K filed on July 21, 2026 under Item 8.01 (Other Events).
• Company cited active operations at Nova Southeastern University’s Center for Collaborative Research in Davie, FL.
• Primary focuses named: regenerative biologic R&D, physician education, and scientific collaboration.
• Press release dated July 21, 2026 is attached as Exhibit 99.1.

Why It Matters
This filing signals Zeo ScientifiX’s strategic emphasis on regenerative medicine and local academic collaboration—information useful for investors tracking the company’s R&D direction and partnerships. The 8-K does not disclose financial terms, funding commitments, or projected timelines; investors should watch for future filings or releases for material updates on partnerships, expenditures, milestones, or regulatory developments.